Aucien Medtech Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 4 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 2415.43%
- Profit Growth 4643.24%
- Ebitda 5288.63%
- Net Worth 2787.39%
- Total Assets 398.66%
About Aucien Medtech
Aucien Medtech Private Limited (AMPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 10 September 2020 (Four years and five months 17 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Titiksha Jain and Rekha Jain serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U33110DL2020PTC369620
- Company No.
369620
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Sep 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
What products or services does Aucien Medtech Private Limited offer?
Aucien Medtech Private Limited offers a wide range of products and services, including Plastic & Glass Labware, Laboratory Plasticware, Volumetric Pipette, Autoclaves, Sterilizers & Incubators, Medical Refrigerator Systems, Medical Laboratory Instruments, PCR Machine, Laboratory Flasks, Laboratory Glass Components, Pathology Lab Equipments.
Who are the key members and board of directors at Aucien Medtech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Titiksha Jain  | Director | 27-Dec-2022 | Current |
| Rekha Jain | Director | 10-Sep-2020 | Current |
Financial Performance of Aucien Medtech.
Aucien Medtech Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 2415.43% increase. The company also saw a substantial improvement in profitability, with a 4643.24% increase in profit. The company's net worth Soared by an impressive increase of 2787.39%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aucien Medtech?
In 2022, Aucien Medtech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Aucien Medtech?
Aucien Medtech has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aucien Medtech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aucien Medtech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
